Comments
Loading...

CASI Pharmaceuticals Analyst Ratings

CASINASDAQ
Logo brought to you by Benzinga Data
Consensus Rating1
Buy
Highest Price Target1
$12.00
Lowest Price Target1
$4.00
Consensus Price Target1
$8.67

CASI Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:CASI | Benzinga

CASI Pharmaceuticals Inc has a consensus price target of $8.67 based on the ratings of 3 analysts. The high is $12 issued by HC Wainwright & Co. on August 15, 2022. The low is $4 issued by HC Wainwright & Co. on April 9, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on April 9, 2025, May 15, 2024, and November 15, 2023, respectively. With an average price target of $7.33 between HC Wainwright & Co., there's an implied 309.68% upside for CASI Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
BTIG
HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for CASI Pharmaceuticals

Buy NowGet Alert
04/09/2025Buy Now123.46%HC Wainwright & Co.
Sean Lee68%
$6 → $4MaintainsBuyGet Alert
05/15/2024Buy Now235.2%HC Wainwright & Co.
Sean Lee68%
$12 → $6MaintainsBuyGet Alert
11/15/2023Buy Now570.39%HC Wainwright & Co.
Sean Lee68%
$10 → $12MaintainsBuyGet Alert
08/14/2023Buy Now458.66%HC Wainwright & Co.
Sean Lee68%
→ $10ReiteratesBuy → BuyGet Alert
05/22/2023Buy Now458.66%HC Wainwright & Co.
Sean Lee68%
→ $10ReiteratesBuy → BuyGet Alert
11/16/2022Buy Now458.66%BTIG
Justin Zelin40%
$21 → $10MaintainsBuyGet Alert
11/15/2022Buy Now458.66%HC Wainwright & Co.
Sean Lee68%
$12 → $10MaintainsBuyGet Alert
08/15/2022Buy Now570.39%HC Wainwright & Co.
Swayampakula Ramakanth51%
$3 → $12MaintainsBuyGet Alert
06/03/2022Buy Now1073.18%BTIG
Justin Zelin40%
$4 → $21MaintainsBuyGet Alert
05/16/2022Buy Now67.6%HC Wainwright & Co.
Sean Lee68%
$4 → $3MaintainsBuyGet Alert

FAQ

Q

What is the target price for CASI Pharmaceuticals (CASI) stock?

A

The latest price target for CASI Pharmaceuticals (NASDAQ:CASI) was reported by HC Wainwright & Co. on April 9, 2025. The analyst firm set a price target for $4.00 expecting CASI to rise to within 12 months (a possible 123.46% upside). 2 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for CASI Pharmaceuticals (CASI)?

A

The latest analyst rating for CASI Pharmaceuticals (NASDAQ:CASI) was provided by HC Wainwright & Co., and CASI Pharmaceuticals maintained their buy rating.

Q

When was the last upgrade for CASI Pharmaceuticals (CASI)?

A

There is no last upgrade for CASI Pharmaceuticals

Q

When was the last downgrade for CASI Pharmaceuticals (CASI)?

A

There is no last downgrade for CASI Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for CASI Pharmaceuticals (CASI)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CASI Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CASI Pharmaceuticals was filed on April 9, 2025 so you should expect the next rating to be made available sometime around April 9, 2026.

Q

Is the Analyst Rating CASI Pharmaceuticals (CASI) correct?

A

While ratings are subjective and will change, the latest CASI Pharmaceuticals (CASI) rating was a maintained with a price target of $6.00 to $4.00. The current price CASI Pharmaceuticals (CASI) is trading at is $1.79, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch